Directly registered : Simply send the application form for transferring securities to your financial intermediary, duly completed and signed. Your financial intermediary will do what is necessary with the Caceis Corporate Trust (14 rue Rouget de Lisle - 92189 Issy les Moulineaux). On receipt of your shares, the Caceis Corporate Trust, a company appointed by Europlasma to manage the registered accounts, will send you the registration certificate for the corresponding account. The Caceis Corporate Trust will therefore become your sole point of contact for your Europlasma securities. A purchase/sale advice will also be sent to you after each transaction carried out on your accont. On 31 December of each year, the Caceis Corporate Trust will send you a statement of account of your securities. The fees incurred for the transfer of securities are determined by your financial intermediary. You must therefore refer to the commissions scale applied by them. To find out the period of time necessary for the transfer of your securities, contact you fiancial intermediary. Registration to a registered account will only be definitive following the effective transfer of your securities by this financial intermediary.

The company has issued redeemable share purchase warrants (BSAR). These warrants allow to subscribe to a new share during a set period of time ("exercise period"), based on a known parity (number of BSAR warrants required to subscribe to a share) and price ("exercise price"). The BSAR are listed on Euronext Paris. From a date determined in the offering circular, these warrants can be redeemed by Europlasma on its initiative at the price of €0.01. When Europlasma triggers the redemption of all or part of the BSAR warrants allocated, the warrant holder can choose between : - Exercising the BSAR and subscribing to new shares at the exercise price; - Selling the BSAR warrants on the market; - Or doing nothing and accepting the redemption of the BSAR warrants concerned by the Europlasma offering at €0.01.

The "BSAR C" are listed on the Alternext Euronext Paris. They have the following characteristics : BSAR C warrant: ISIN code : FR0013294089 Exercise price : 0.32€/share from 03/11/2017 to 30/06/2018 and then 0.75€/share from 01/07/2018 to 31/12/2021 Exercise parity : 4 BSAR B warrants entitle holders to subscribe to 1 new share Following stock split operation, exercise parity and price must be multiplied by 2,000 since 7 July 2020. Exercise period : from 03/11/2017 to 31/12/2021 Rights are attached to the BSAR warrants : BSAR warrants entitle holders to subscribe to new Europlasma shares at any time during the exercise period, according to the terms described above. They do not entitle holders to voting rights during General Meetings or to receive dividends.